Related Experiment Video
Updated: Oct 10, 2025
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.8K
Using epigenetic modifiers to target cancer stem cell immunoevasion.
Claudia Galassi1, Ilio Vitale2, Lorenzo Galluzzi3
1Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
Cancer Cell
|December 15, 2021
Summary
Melanoma cells evade immune detection by epigenetically silencing endogenous retroelements via SET domain bifurcated histone lysine methyltransferase 1 (SETDB1). This mechanism, active in stem cells, offers a new strategy to restore cancer stem cell immunosurveillance.
Area of Science:
- Epigenetics
- Immunology
- Cancer Biology
Background:
- Melanoma cells employ immunoevasion strategies to escape immune detection.
- Endogenous retroelements are DNA sequences that can be epigenetically regulated.
- Cancer stem cells play a crucial role in tumor recurrence and immune evasion.
Purpose of the Study:
- To elucidate a novel mechanism of immunoevasion in melanoma.
- To investigate the role of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in epigenetic regulation of endogenous retroelements.
- To explore strategies for restoring cancer stem cell immunosurveillance.
Main Methods:
- Analysis of gene expression data from melanoma samples.
- Epigenetic analysis focusing on histone modifications.
- Investigating the function of SETDB1 in regulating endogenous retroelements.
Main Results:
- SETDB1-dependent epigenetic suppression of endogenous retroelements was identified as a key immunoevasion mechanism in melanoma.
- SETDB1 is highly expressed in the stem cell compartment of melanoma.
- This suppression contributes to the escape of melanoma cells from immune surveillance.
Conclusions:
- The findings reveal a novel pathway for melanoma immunoevasion.
- Targeting SETDB1 or reactivating endogenous retroelements could be a therapeutic strategy.
- Restoring cancer stem cell immunosurveillance is a promising avenue for melanoma treatment.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
5.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:27Tumor Immunotherapy
723
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
723
02:38Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:37Epigenetic Regulation
3.2K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.2K